Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutamide for Prostate Cancer Prevention in Men with High Grade PIN
NCT00006214Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2000
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Flutamide with Placebo (2 arms). Primary endpoint: Incidence of prostate cancer at 10 years. Started Aug 2000; status: completed.
02
Drugs
flutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00006214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006214.